drugset / Trial / NCT06006416

Effect of Fenugreek Fibre on Gut Microbiome

NCT06006416 ↗

Phase 3 Withdrawn RDC Clinical Pty Ltd
NaSingle-groupOpen-labelTreatment

Summary

A open label, self-controlled trial to evaluate the effect of Fenugreek Fibre (Trigonella foenum-graecum) on the gut microbiome in generally healthy adults aged 18-65 years old.

Timeline

Start
2024-12
Primary completion
2025-05-01
Completion
2025-09-01

Outcome

Outcome not reported

Stopped: “The Sponsor decided not to conduct the study.”

Drugs

EvaluationDrugModalityDoseRoute
Subject Fenugreek Fibre Unknown 10 g —

Indications

No indication recorded.